IceCure Medical (ICCM) Change in Working Capital (2020 - 2024)

IceCure Medical's (ICCM) quarterly Change in Working Capital came in at $64000.0 in Q1 2024, down 65.96% year-on-year from $188000.0 in Q2 2023, and down 65.96% on a QoQ basis from $188000.0 in Q1 2023.

IceCure Medical (ICCM) Change in Working Capital (2020 - 2024) Analysis & Trends

IceCure Medical (ICCM) has 5 years of Change in Working Capital data on file, last reported at $64000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -128.78 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 IceCure Medical 7.92 Mn -193,612.29 295,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2024 64,000.00
Mar 31, 2024 64,000.00
Mar 31, 2023 188,000.00
Mar 31, 2023 188,000.00
Sep 30, 2022 276,000.00
Sep 30, 2022 276,000.00
Jun 30, 2022 -852,000.00
Jun 30, 2022 -852,000.00
Mar 31, 2022 1.13 Mn
Mar 31, 2022 1.13 Mn
Sep 30, 2021 269,000.00
Sep 30, 2021 269,000.00
Sep 30, 2020 14,000.00
Sep 30, 2020 14,000.00